Australia invests $50 M into BioMedTech Incubator programme
Singapore, March 23 -- Brandon BioCatalyst, in partnership with ANDHealth, has been selected by the Federal Government to deliver the $50 million BioMedTech Incubator (BMTI) programme. The investment, from the $20 billion Medical Research Future fund (MRFF) in Australia, substantially increases the grant funding available through existing Brandon BioCatalyst and ANDHealth programmes to more than $115 million.
The BMTI programme will leverage the highly specialised selection, assessment and growth capabilities which have been built through CUREator, the Brandon BioCatalyst managed national biotech incubator, and ANDHealth+, the ANDHealth managed national digital health accelerator.
The new BMTI programme, which commences later this year,...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.